These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16105146)

  • 1. Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin.
    Chan CH; Liu TW; Chen LT; Chang JY; Whang-Peng J
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1470-1. PubMed ID: 16105146
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.
    Ma Y; Qin H; Zheng Q; Wang Y; Wang Z; Yang Z
    Med Oncol; 2010 Dec; 27(4):1089-95. PubMed ID: 19885749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.
    Kos FT; Uncu D; Ozdemir N; Budakoglu B; Odabaş H; Abali H; Oksuzoglu B; Aksoy S; Zengin N
    Chemotherapy; 2011; 57(3):230-5. PubMed ID: 21597287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of combined treatment of patients with metastatic gastric cancer. Case study].
    Trusilova EV; Besova NS; Bagrova SG; Gorbunova VA; Stilidi IS; Nered SN
    Vopr Onkol; 2013; 59(1):123-5. PubMed ID: 23814839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study.
    Constenla M; Garcia-Arroyo R; Lorenzo I; Carrete N; Campos B; Palacios P
    Gastric Cancer; 2002; 5(3):142-7. PubMed ID: 12378340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
    Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli AM; Catalano G
    Br J Cancer; 2001 Feb; 84(4):470-4. PubMed ID: 11207039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biweekly regimen of high dose of leucovorin, 5-fluorouracil, and paclitaxel for patients with advanced gastric cancer].
    Feng JF; Lu JW; Sun XF
    Ai Zheng; 2004 Dec; 23(12):1704-6. PubMed ID: 15601565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer.
    Wang B; Zhang W; Hong X; Guo Y; Li J
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):213-8. PubMed ID: 18343924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
    Di Bartolomeo M; Buzzoni R; Mariani L; Ferrario E; Katia D; Gevorgyan A; Zilembo N; Bordonaro R; Bochicchio AM; Massidda B; Ardizzoia A; Marini G; Aitini E; Schieppati G; Comella G; Pinotti G; Palazzo S; Cicero G; Bajetta E; ; Villa E; Fagnani D; Reguzzoni G; Agostana B; Oliani C; Kildani B; Duro M; Botta M; Mozzana R; Mantovani G
    Oncology; 2006; 71(5-6):341-6. PubMed ID: 17855795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma.
    Guo Mg; Zheng Q; zhong Di J; Yang Z
    World J Surg Oncol; 2014 May; 12():150. PubMed ID: 24885421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Docetaxel-Cisplatin-5-Fu Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer].
    Kim JH; Lee YC
    Korean J Gastroenterol; 2007 Sep; 50(3):207-209. PubMed ID: 18975451
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
    Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
    Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stage IV gastric cancer and FOLFOX 6. Case report].
    Forti L; Miraglia S; Carnio S; Bighiani S; Alabiso I; Alabiso O
    Tumori; 2003; 89(4 Suppl):66. PubMed ID: 12903551
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
    Thuss-Patience PC; Kretzschmar A; Krenn V; Dörken B; Reichardt P
    Onkologie; 2003 Feb; 26(1):63-5. PubMed ID: 12624520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study.
    Li ZY; Tang L; Zhang LH; Bu ZD; Wu AW; Wu XJ; Zong XL; Wu Q; Shan F; Li SX; Ren H; Zhang XP; Ji JF
    Med Oncol; 2010 Dec; 27(4):1314-8. PubMed ID: 19967569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
    Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report: multiple liver metastasis of gastric cancer responding to intraarterial infusion of MTX and 5-FU].
    Ota Y; Nakano Y; Yamaguchi H; Yoshida K; Shirafuji T; Adachi A
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1055-7. PubMed ID: 8512333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer.
    Shen YC; Li CP; Yen CJ; Hsu C; Lin YL; Lin ZZ; Chen LT; Su WC; Chao Y; Yeh KH; Cheng AL
    Oncology; 2014; 87(2):104-13. PubMed ID: 25011938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.